Showing results (11-20 of 1,028) with videos related to

Sort By:
Pageof 103
The Lancet. Respiratory Medicine|August 14, 2019
The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysisIrena F Laska, Megan L Crichton, Amelia Shoemark, et al.
The Lancet. Respiratory Medicine|October 4, 2019
Diagnostic accuracy of transbronchial lung cryobiopsy for interstitial lung disease diagnosis (COLDICE): a prospective, comparative studyLauren K Troy, Christopher Grainge, Tamera J Corte, et al.
The Lancet. Respiratory Medicine|October 9, 2019
Challenges in the diagnosis of paediatric pneumonia in intervention field trials: recommendations from a pneumonia field trial working groupDina Goodman, Mary E Crocker, Farhan Pervaiz, et al.
The Lancet. Respiratory Medicine|February 1, 2021
Safety and effectiveness of bronchial thermoplasty after 10 years in patients with persistent asthma (BT10+): a follow-up of three randomised controlled trialsRekha Chaudhuri, Adalberto Rubin, Kaharu Sumino, et al.
The Lancet. Respiratory Medicine|January 30, 2021
Switch-maintenance gemcitabine after first-line chemotherapy in patients with malignant mesothelioma (NVALT19): an investigator-initiated, randomised, open-label, phase 2 trialCornedine J de Gooijer, Vincent van der Noort, Jos A Stigt, et al.
The Lancet. Respiratory Medicine|December 6, 2021
Post-mortem lung tissue: the fossil record of the pathophysiology and immunopathology of severe COVID-19Luke Milross, Joaquim Majo, Nigel Cooper, et al.
The Lancet. Respiratory Medicine|February 12, 2022
High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: a randomised, placebo-controlled trialAndrea Alemany, Pere Millat-Martinez, Marc Corbacho-Monné, et al.
The Lancet. Respiratory Medicine|June 11, 2019
Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP): a multicentre, randomised, double-blind, placebo-controlled trialFelix Ratjen, Stephanie D Davis, Sanja Stanojevic, et al.
The Lancet. Respiratory Medicine|June 12, 2019
Pathophysiological role of respiratory dysbiosis in hospital-acquired pneumoniaA Roquilly, A Torres, J A Villadangos, et al.
The Lancet. Respiratory Medicine|March 27, 2022
Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease (COPD-ST2OP): a phase 2a, placebo-controlled trialAhmed J Yousuf, Seid Mohammed, Liesl Carr, et al.
Pageof 103